The impact of severe nephrotic syndrome on thyroid function, nutrition and coagulation
Clinical Kidney Journal · 02.09.2024 · 17 (9)
DOI: 10.1093/ckj/sfae280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 04.09.2024. Verfasst von Anna Matyjek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine - National Research Institute, Warsaw, Poland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Military Institute of Medicine.
Abstract (Originalsprache)
Background
Nephrotic syndrome (NS) is characterized by urinary loss of proteins, including hormones and their carrier proteins, potentially resulting in endocrine disorders. This study aimed to assess thyroid dysfunction frequency and potential implications in NS.
Methods
In this case–control study, patients with severe NS (serum albumin ≤2.5 g/dl) and controls without proteinuria were evaluated for thyroid, haemostatic and nutritional parameters, including body composition.
Results
A total of 42 nephrotic and 40 non-proteinuric patients were enrolled. The NS group showed higher thyroid-stimulating hormone and lower free hormones, corresponding to a higher frequency of both euthyroid sick syndrome {ESS; 36% versus 5%; odds ratio [OR] 10.6 [95% confidence interval (CI) 2.2–50.0]} and hypothyroidism [31% versus 5%; OR 8.5 (95% CI 1.8–40.7)] compared with the control group. Levothyroxine supplementation was required for 11 NS patients (26% of the NS group). In addition, compared with control individuals, NS patients exhibited lower lean tissue mass and a trend towards hypercoagulability, which was evidenced by higher levels of most coagulation factors and fibrinolysis inhibitors, and reduced endogenous anticoagulants activities. Furthermore, NS patients with ESS presented with a 10.4 kg (95% CI −18.68 to −2.12) lower lean tissue mass. Those with hypothyroidism had significantly reduced activity of coagulation factor X [by −30% (95% CI −47 to −13)] and protein S [by −27% (95% CI −41 to −13)] compared with euthyroid NS individuals.
Conclusions
Thyroid dysfunction is common in severe NS, often necessitating levothyroxine supplementation, which supports routine thyroid workup. A potential link between thyroid, nutritional and coagulation disorders in NS requires further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
- Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
- Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.
- Department of Laboratory Diagnostics, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Anna Matyjek
Förderung
- Military Institute of Medicine
Zitieren
APA
Matyjek, A., Niemczyk, S., Literacki, S., Fendler, W., Rozmysłowicz, T., & Kronbichler, A. (2024). The impact of severe nephrotic syndrome on thyroid function, nutrition and coagulation. Clinical Kidney Journal, 17(9). https://doi.org/10.1093/ckj/sfae280
Vancouver
Matyjek A, Niemczyk S, Literacki S, Fendler W, Rozmysłowicz T, Kronbichler A. The impact of severe nephrotic syndrome on thyroid function, nutrition and coagulation. Clinical Kidney Journal. 2024;17(9). doi:10.1093/ckj/sfae280
BibTeX
@article{Matyjek2024,
author = {Matyjek, Anna and Niemczyk, Stanisław and Literacki, Sławomir and Fendler, Wojciech and Rozmysłowicz, Tomasz and Kronbichler, Andreas},
title = {The impact of severe nephrotic syndrome on thyroid function, nutrition and coagulation},
journal = {Clinical Kidney Journal},
year = {2024},
volume = {17},
number = {9},
doi = {10.1093/ckj/sfae280}
}
EUVIMED